The content is available as a PDF (350.8 KB).
Footnotes
Disclaimer
This article represents the personal opinions of the authors and does not reflect the institutional opinion of their employers.
References
- 1.Jordan RE, Adab P, Cheng KK. Covid-19: Risk factors for severe disease and death. BMJ. 2020;368:m1198. doi: 10.1136/bmj.m1198. [DOI] [PubMed] [Google Scholar]
- 2.Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis. 2020 Mar 25. Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30198-5/fulltext. Accessed April 17, 2020. [DOI] [PMC free article] [PubMed]
- 3.Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020. Available from: https://wwwnc.cdc.gov/eid/article/26/7/20-0282article. Accessed April 17, 2020. [DOI] [PMC free article] [PubMed]
- 4.Salje H, Kiem CT, Lefrancq N, Courtejoie N, Bosetti P, PaireauJ, et al. Estimating the burden of SARS-CoV-2 in France.2020. ffpasteur-02548181f. Available from: https://hal-pasteur.archives-ouvertes.fr/pasteur-02548181/document. Accessed April 17, 2020. [DOI] [PMC free article] [PubMed]
- 5.Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) Science. 2020;368:489–93. doi: 10.1126/science.abb3221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New Engl J Med. 2020;382:1177–9. doi: 10.1056/NEJMc2001737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006;11:49–53. doi: 10.1111/j.1440-1843.2006.00783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, et al. Persistence of antibodies against Middle-East respiratory syndrome coronavirus. Emerg Infect Dis. 2020;22:1824–6. doi: 10.3201/eid2210.160706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Okba NMA, Müller MA, Li W, Wang C, vanKessel CHG, Corman VM, et al. Severe acute respiratory syndrome coronavirus 2 specific antibody responses in coronavirus disease 2019 patients.Emerg Infect Dis. 2020 Apr 8. Available from: https://wwwnc.cdc.gov/eid/article/26/7/200841_article. Accessed April 17, 2020. [DOI] [PMC free article] [PubMed]
- 10.Mandal S, Bhatnagar T, Arinaminpathy N, Agarwal A, Chowdhury A, Murhekar M, et al. Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach. Indian J Med Res. 2020;151:190–9. doi: 10.4103/ijmr.IJMR_504_20. [DOI] [PMC free article] [PubMed] [Google Scholar]